Facts and future lines of research in prostate cancer: concluding remarks

被引：1

作者：

Abrams, P ^{[1
]}

机构：

[1] Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England

来源：

BJU INTERNATIONAL | 2000年 / 85卷

关键词：

D O I：

10.1046/j.1464-410X.2000.00065.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：49 / 51

页数：3

共 9 条

[1] α1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia [J].

Chon, JK ;

Borkowski, A ;

Partin, AW ;

Isaacs, JT ;

Jacobs, SC ;

Kyprianou, N .

JOURNAL OF UROLOGY, 1999, 161 (06) :2002-2008

[2] Overview: Hormone refractory prostate cancer [J].

Crawford, ED ;

Rosenblum, M ;

Ziada, AM ;

Lange, PH .

UROLOGY, 1999, 54 (6A) :1-7

[3] Molecular regulation of cell death and therapeutic strategies for cell death induction in prostate carcinoma [J].

Gjertsen, BT ;

Logothetis, CJ ;

McDonnell, TJ .

CANCER AND METASTASIS REVIEWS, 1998, 17 (04) :345-351

[4]

Hegarty NJ, 1999, PROSTATE, V40, P261, DOI 10.1002/(SICI)1097-0045(19990901)40:4<261::AID-PROS8>3.0.CO

[5]

2-H

[6] Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia [J].

Kyprianou, N ;

Litvak, JP ;

Borkowski, A ;

Alexander, R ;

Jacobs, SC .

JOURNAL OF UROLOGY, 1998, 159 (06) :1810-1815

[7] Angiogenesis, p53, bcl-2 and ki-67 in the progression of prostate cancer after radical prostatectomy [J].

Moul, JV .

EUROPEAN UROLOGY, 1999, 35 (5-6) :399-407

[8] Gene therapy for prostate cancer - New perspectives on an old problem [J].

Palapattu, GS ;

Naitoh, J ;

Belldegrun, AS .

UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (02) :353-+

[9] Vaccine therapy for prostate cancer [J].

Tjoa, BA ;

Elgamal, AAA ;

Murphy, GP .

UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (02) :365-+

← 1 →